Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Questionnaire survey of California consumers' use and rating of sources of health care information including the Internet.
2000
Assessing Readiness to Change among Clients Seeking Help for Hypersexual Behavior
2007
Methods of HIV Disclosure by Men Who Have Sex with Men to Casual Sexual Partners
2005
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Parenteral Anticoagulants
2012 Standout
Self-efficacy and disclosure of HIV-positive serostatus to sex partners.
1999
A taxonomy of behavior change techniques used in interventions.
2008 Standout
Prevalence of Left Atrial Thrombus and Dense Spontaneous Echo Contrast in Patients With Short-Term Atrial Fibrillation < 48 Hours Undergoing Cardioversion: Value of Transesophageal Echocardiography to Guide Cardioversion
2009
Ulcerative Colitis
2011 Standout
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States
2005 Standout
Stress, Social Support, and HIV-Status Disclosure to Family and Friends Among HIV-Positive Men and Women
2003
Oral Anticoagulant Therapy
2012 Standout
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
2009
Women's self-disclosure of HIV infection: Rates, reasons, and reactions.
1995
Consumer health information seeking on the Internet: the state of the art
2001 Standout
The disclosure processes model: Understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity.
2010 Standout
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
The health and welfare needs of female and transgender street sex workers in New South Wales
2001
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
2003
Use of the Internet and E-mail for Health Care Information
2003 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Developing and evaluating complex interventions: the new Medical Research Council guidance
2008 Standout
Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife
2017
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
2009 StandoutNobel
Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence.
2006 Standout
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis
2012 Standout
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
2004
Antithrombotic Therapy in Atrial Fibrillation
2004
The role of vagal function in the risk for cardiovascular disease and mortality
2006 Standout
Relation of Vigorous Exercise to Risk of Atrial Fibrillation
2009
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
2003
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
2006
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues
2003
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
2005
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation
2006
Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias
2006
Transcatheter closure of patent foramen ovale in older adults
2006
The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors
2009 Standout
Infectious syphilis in high-income settings in the 21st century
2008
Rate vs Rhythm Control in Patients With Atrial Fibrillation
2005
Effective techniques in healthy eating and physical activity interventions: A meta-regression.
2009 Standout
Antithrombotic Therapy in Atrial Fibrillation
2008
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Box-Jenkins modelling in medical research
1996
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility
1999
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
2005
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Reasons for HIV Disclosure/Nondisclosure in Close Relationships: Testing a Model of HIV–Disclosure Decision Making
2004
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation
2005
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation
2003
Interventions to change health behaviours: evidence-based or evidence-inspired?
2004
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Mortality in Patients After a Recent Myocardial Infarction
2004
Works of Daniel Schnell being referenced
A time series analysis of gonorrhea surveillance data
1989
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response
2000
Men's disclosure of HIV test results to male primary sex partners.
1992
Time series analysis of syphilis surveillance data
1989
Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: Efficacy and dose-response
2002
Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials
2003
Sources of HIV information among injecting drug users: Association with gender, ethnicity, and risk behaviour
1996
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation
2001
Testosterone Reference Ranges in Normally Cycling Healthy Premenopausal Women
2011
Sources of HIV/AIDS information among female sex traders
1995
1049 Identification of Items to Be Included in An Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
2009
Asymptomatic or “Silent” Atrial Fibrillation
2003
Stages of condom use in a high HIV-risk sample
1999